ArticleBritish journal of clinical pharmacology2026

Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.

Pernille D Haahr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.